CDK2 INHIBITORS AND METHODS OF USING THE SAME

The present disclosure relates generally to Cyclin-dependent kinase 2 (CDK2) inhibiting chemical compounds and uses thereof in the inhibition of the activity of CDK2. The disclosure also provides pharmaceutically acceptable compositions comprising compounds disclosed herein and methods of using said...

Full description

Saved in:
Bibliographic Details
Main Authors MICHOWSKI, WOJTEK, PORTER, JR, KIRMAN, LOUISE CLARE, RIPPER, JUSTIN, SCHWARTZ, CARL ERIC, FEUTRILL, JOHN
Format Patent
LanguageEnglish
French
Published 29.12.2022
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates generally to Cyclin-dependent kinase 2 (CDK2) inhibiting chemical compounds and uses thereof in the inhibition of the activity of CDK2. The disclosure also provides pharmaceutically acceptable compositions comprising compounds disclosed herein and methods of using said compounds and compositions in the treatment of various disorders related to CDK2 activity. La présente invention concerne de manière générale des composés chimiques inhibiteurs de la kinase cycline-dépendante 2 (CDK2) et leurs utilisations dans l'inhibition de l'activité de la CDK2. L'invention concerne également des compositions pharmaceutiquement acceptables comprenant les composés de l'invention et des procédés d'utilisation desdits composés et compositions dans le traitement de divers troubles liés à l'activité de la CDK2.
Bibliography:Application Number: CA20223225439